» Articles » PMID: 21070840

Novel Insights into CaMKII Function and Regulation During Memory Formation

Overview
Journal Brain Res Bull
Specialty Neurology
Date 2010 Nov 13
PMID 21070840
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Ca(2+)/calmodulin-dependent kinase II (CaMKII) is an abundant synaptic signalling molecule that is essential for memory formation and the induction of synaptic potentiation. Additionally, CaMKII plays a prominent role in synaptic tagging and metaplasticity. These abilities are mediated by kinase activity as well as binding to a wide variety of synaptic proteins, including NMDA receptor subunits, modulating CaMKII location and activity. A characteristic feature is that autophosphorylation of CaMKII switches the kinase into autonomous activity. Since CaMKII can be autonomously active and because CaMKII is required for the formation of memory it is important that the kinase activity is adequately switched off. However, the exact time window of increased activity and how this is terminated, it is still matter of debate. After training in a memory task CaMKII activity is increased for at least 30 min. This CaMKII activity and further activation of CaMKII may be regulated by changes in the expression of two endogenous CaMKII inhibitor proteins, CaMKII inhibitor Alpha and Beta, as they are up-regulated early after training. These endogenous inhibitors specifically block CaMKII activity and they inhibit the association with NMDA receptor subunits. Thus, regulation of the expression of endogenous CaMKII inhibitors may constitute a novel negative feedback on CaMKII signalling during memory formation.

Citing Articles

Towards Kinase Inhibitor Therapies for Fragile X Syndrome: Tweaking Twists in the Autism Spectrum Kinase Signaling Network.

DIncal C, Broos J, Torfs T, Kooy R, Vanden Berghe W Cells. 2022; 11(8).

PMID: 35456004 PMC: 9029738. DOI: 10.3390/cells11081325.


Mild Traumatic Brain Injury-Induced Disruption of the Blood-Brain Barrier Triggers an Atypical Neuronal Response.

Munoz-Ballester C, Mahmutovic D, Rafiqzad Y, Korot A, Robel S Front Cell Neurosci. 2022; 16:821885.

PMID: 35250487 PMC: 8894613. DOI: 10.3389/fncel.2022.821885.


Inhibition of phosphorylated calcium/calmodulin-dependent protein kinase IIα relieves streptozotocin-induced diabetic neuropathic pain through regulation of P2X3 receptor in dorsal root ganglia.

He X, Kang Y, Fei X, Chen L, Li X, Ma Y Purinergic Signal. 2022; 19(1):99-111.

PMID: 34973115 PMC: 9984656. DOI: 10.1007/s11302-021-09829-z.


A brain proteomic signature of incipient Alzheimer's disease in young ε4 carriers identifies novel drug targets.

Roberts J, Varma V, An Y, Varma S, Candia J, Fantoni G Sci Adv. 2021; 7(46):eabi8178.

PMID: 34757788 PMC: 8580310. DOI: 10.1126/sciadv.abi8178.


CaMKIIα Expressing Neurons to Report Activity-Related Endogenous Hypoxia upon Motor-Cognitive Challenge.

Butt U, Hassouna I, Garcia-Agudo L, Steixner-Kumar A, Depp C, Barnkothe N Int J Mol Sci. 2021; 22(6).

PMID: 33804598 PMC: 8003772. DOI: 10.3390/ijms22063164.